Cancer treatments account for 9.3% of total drug claims in 2020

Korea Biomedical Review

1 September 2021 - The National Health Insurance Service (NHIS) said that the reimbursement claims for anticancer drugs last year amounted to about 1.91 trillion won ($1.6 billion), accounting for 9.3% of the total drug reimbursement payouts of 20.3 trillion won.

According to the NHIS, medical expenses for health insurance last year stood at 86.9 trillion won, and drug expenses accounted for 23.6%, with 20.3 trillion won.

Read Korea Biomedical Review article

Michael Wonder

Posted by:

Michael Wonder